Clarivate PLC (CLVT) reported $621.2 million in revenue for the quarter ended March 2024, representing a year-over-year decline of 1.3%. EPS of $0.14 for the same period compares to $0.18 a year ago.The reported revenue represents a surprise of +1.08% over the Zacks Consensus Estimate of $614.57 million. With the consensus EPS estimate being $0.14, the company has not delivered EPS surprise.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compa ...

Clarivate PLC (CLVT) came out with quarterly earnings of $0.14 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.18 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this company would post earnings of $0.21 per share when it actually produced earnings of $0.23, delivering a surprise of 9.52%.Over the last four quarters, the company has surpassed consensus EPS estimates three times.Clarivate, which belongs to the ...

Jersey, Channel Islands N/A (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 70 St. Mary Axe London EC3A 8BE United Kingdom (Address of principal executive offices) Not applicable (Zip Code) Registrant's telephone number, including area code: +44 207 4334000 Securities registered pursuant to Section 12(b) of the Act: | --- | --- | --- | |-------------------------------------------------------------------------------------|---------------------|------------- ...

Clarivate Reports First Quarter 2024 Results London, UK -- May 8, 2024 Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the first quarter ended March 31, 2024. • Revenues of $621.2 million decreased 1.3% • Net loss attributable to ordinary shares of $93.8 million; Net loss per diluted share of $0.14 (1) • Net cash provided by operating activities of $176.2 million decreased $51.3 million; Free cash flow of $111.8 ...

Empowering biopharma with unified epidemiology, incidence and prevalence data alongside claims-based population insights, for precise market sizing and patient population analysis LONDON, May 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of Epidemiology Intelligence™. The new solution combines rich insights from epidemiology, incidence and prevalence database solutions. It includes U.S. claims-based population insight ...

Enhancements enable pharma, biotech and generics companies to streamline regulatory tracking and optimize life cycle management for small molecules and biologics  LONDON, May 2, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of the newly enhanced Cortellis CMC Intelligence™ solution, featuring a new post-approval variations module. The module for post-approval variations covers regulatory changes across multiple countries, ...

The market expects Clarivate PLC (CLVT) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released ...

Three-part report investigates rapid pipeline growth, partnerships, clinical trials, and patient access challenges in cancer treatment LONDON, April 30, 2024 /PRNewswire/ -- BioWorld™ published by  Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, explores the growing investment in CAR T therapy development in mainland China in a new series titled "China's CAR T market comes of age." The report examines the dynamic realm of CAR T-cell therapies in China, including the rapi ...

LONDON, April 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announces it has signed the United Nations Sustainable Development Goals (UN SDGs) Publishers Compact. Signatories of the compact pledge to develop sustainable practices and act as champions of the SDGs during the Decade of Action (2020-2030). Liliana Hinderman, Senior Vice President, Chief Risk and Sustainability Officer said: "We have signed the UN SDG Publishers Compact as a c ...

Acquisition supports critical client workflow and reporting needs with proprietary SaaS platform, automating regulatory report authoring and compliance across manufacturing operations, supply chain and quality management LONDON, April 23, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced that it has acquired Global QMS, Inc., known as Global Q, a provider of cloud-based solutions that enable life sciences clients to automate regulatory ...